CPRX icon

Catalyst Pharmaceutical

138 hedge funds and large institutions have $376M invested in Catalyst Pharmaceutical in 2021 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 39 increasing their positions, 57 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

less ownership

Funds ownership:

32% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 57

75% less call options, than puts

Call options by funds: $634K | Put options by funds: $2.57M

Holders
138
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$634K
Puts
$2.57M
Net Calls
Net Calls Change

Top Buyers

1 +$16.3M
2 +$4.5M
3 +$3.79M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.74M
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$1.65M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$57.5M
2
$46M
3
$34.5M
4
$28.7M
5
$24.4M
6
$17.7M
7
$11.1M
8
$10.7M
9
$8.4M
10
$8.19M
11
$7.65M
12
$6.24M
13
$6.14M
14
$5.24M
15
$4.6M
16
$4.54M
17
$4.49M
18
$3.97M
19
$3.61M
20
$3.6M
21
$3.57M
22
$3.51M
23
$2.78M
24
$2.6M
25
$2.28M